Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) today reported that Michael MacDonald has been promoted to SVP and General Manager of Diagnostics. In this role, Mr. MacDonald will oversee the Company's diagnostic products which include DPNCheck ® and ADVANCE™. Mr.
View HTML
Toggle Summary NeuroMetrix Provides Update on Quell Health Cloud Including Promotion of Dr. Xuan Kong to Chief Data Scientist
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) today provided an update on its data science initiative and the related Quell ® Health Cloud. Data science consists of the development of large cloud databases and the use of powerful analytical tools such as machine learning and
View HTML
Toggle Summary NeuroMetrix Provides Update on Quell Wearable Pain Relief Clinical Program
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) today provided an update on its Quell ® clinical program. Quell is a wearable non-invasive neurostimulator that provides widespread analgesia for chronic pain. In addition to delivery of therapy, the device and its associated
View HTML
Toggle Summary NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,675,801. The patent covers novel mechanisms to help Quell ® users safely obtain pain relief therapy over prolonged time periods.
View HTML
Toggle Summary NeuroMetrix to Present at the Marcum Microcap Conference on June 16, 2017
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix , is scheduled to speak at the upcoming 2017 Marcum Microcap Conference at the Grand Hyatt Hotel in New York City. Dr.
View HTML
Toggle Summary NeuroMetrix Exhibits Quell Wearable Technology at 31st Annual SLEEP Meeting
Waltham -based company to exhibit its wearable device for widespread chronic pain relief BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc.  (Nasdaq: NURO) is showing  Quell ® , its 100% drug-free Wearable Pain Relief Technology™ to sleep medicine professionals from around the world at SLEEP 2017 , the
View HTML
Toggle Summary NeuroMetrix to Present at the LD Micro Invitational Conference on June 6, 2017
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix , is scheduled to speak at the upcoming LD Micro Invitational at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. Dr.
View HTML
Toggle Summary NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,656,070. The patent covers the novel application of real-time accelerometer measurements to control transcutaneous electrical nerve stimulation.
View HTML
Toggle Summary NeuroMetrix Wins SBANE New England Innovation Award
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO) announced that it was the recipient of the Smaller Businesses Association of New England (SBANE) New England Innovation Award for the development and successful launch of Quell ® Wearable Pain Relief Technology™.
View HTML
Toggle Summary NeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain
Blog to serve as a resource on issues and topics related to chronic pain, such as digital medicine and alternative treatments WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc . (Nasdaq: NURO) today announced the launch of LivingQuell , a blog that will serve as an online resource for people
View HTML